The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-{[(3R,5R)-5-(4-hydroxyphenyl)-1-methylpiperidin-3-yl]-amino}-3-methyl-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one ID: ALA4570924
PubChem CID: 155562459
Max Phase: Preclinical
Molecular Formula: C19H23N5O2
Molecular Weight: 353.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc(O)cc2)C1
Standard InChI: InChI=1S/C19H23N5O2/c1-23-10-13(12-3-5-15(25)6-4-12)9-14(11-23)21-19-22-16-7-8-20-17(16)18(26)24(19)2/h3-8,13-14,20,25H,9-11H2,1-2H3,(H,21,22)/t13-,14+/m0/s1
Standard InChI Key: BXMGYRODWDXVQJ-UONOGXRCSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
5.4397 -3.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4397 -4.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1491 -5.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8585 -4.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8585 -3.8961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1491 -3.4834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5656 -5.1312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2780 -4.7195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9876 -5.1341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6996 -4.7231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2760 -3.9007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9850 -3.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6971 -3.9030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3115 -3.3568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9765 -2.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1577 -2.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4117 -5.1354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9855 -5.9554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7284 -5.1312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -4.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3059 -5.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3067 -5.9535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0241 -6.3609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7319 -5.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1491 -2.6621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5960 -6.3641 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
4 7 1 6
7 8 1 0
8 9 1 0
9 10 1 0
10 13 1 0
12 11 1 0
11 8 2 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
10 17 2 0
9 18 1 0
2 19 1 6
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
6 25 1 0
22 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.43Molecular Weight (Monoisotopic): 353.1852AlogP: 1.87#Rotatable Bonds: 3Polar Surface Area: 86.18Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.19CX Basic pKa: 7.77CX LogP: 1.68CX LogD: 1.13Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.67Np Likeness Score: -0.03
References 1. Huang L, Li H, Li L, Niu L, Seupel R, Wu C, Cheng W, Chen C, Ding B, Brennan PE, Yang S.. (2019) Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain., 62 (9): [PMID:30998845 ] [10.1021/acs.jmedchem.9b00096 ]